If you have been diagnosed with keratoconus, learning about your treatment options can quickly become overwhelming. You may hear about corneal cross-linking, CTAK, specialized contact lenses, and procedures such as DALK or full-thickness corneal transplantation. How do you know which one you actually need? The answer depends on what your cornea needs.
Different keratoconus treatments accomplish different goals. Some are designed to stop the condition from progressing. Others can improve the shape of the cornea or help you see more clearly. In advanced cases, damaged corneal tissue may need to be replaced. Understanding these different goals makes it easier to see where CTAK fits into modern keratoconus treatment.
First: Stabilizing the Cornea With Cross-Linking
One of the first questions we consider when evaluating keratoconus is whether the cornea is stable. Keratoconus causes the cornea to progressively thin, weaken, and change shape. Corneal cross-linking (CXL) is designed to strengthen the cornea and slow or stop this progression. This makes cross-linking particularly important for patients whose testing shows that their keratoconus is continuing to progress. However, stabilization and reshaping are two different goals.
While cross-linking may produce some flattening or changes in corneal shape, its primary purpose is not to correct the irregular shape that keratoconus has already created. A patient’s keratoconus may therefore be stable after cross-linking while significant corneal irregularity and visual distortion remain. That is where additional treatments may come into the picture.
CTAK: Improving the Shape of the Cornea
CTAK, or Corneal Tissue Addition Keratoplasty, takes a different approach to keratoconus treatment. Rather than removing or replacing the cornea, the CTAK procedure adds precisely shaped donor corneal tissue to the patient’s existing cornea. These customized tissue segments are designed based on the individual patient’s corneal measurements and are placed within the cornea to improve its shape. The goal is to make an irregular, cone-shaped cornea more regular.
By improving corneal shape and symmetry, CTAK may reduce irregular astigmatism and create a better optical surface. This can potentially improve vision and may also help patients achieve better vision with glasses or contact lenses. CTAK can therefore fill an important space in keratoconus care: the space between stabilizing the disease and replacing the cornea.
When Is a Corneal Transplant Needed?
For some patients with advanced keratoconus, particularly when there is significant corneal scarring or other severe changes, a corneal transplant may still be necessary. However, “corneal transplant” can refer to different procedures.
One option is Deep Anterior Lamellar Keratoplasty (DALK). During DALK eye surgery, the damaged front layers of the cornea are replaced with healthy donor tissue while the patient’s own inner endothelial layer is preserved. Because healthy tissue is retained, DALK can offer important advantages over replacing the entire cornea when a patient’s endothelium remains healthy.
A Penetrating Keratoplasty (PK) is a full-thickness corneal transplant. In this procedure, the full thickness of the patient’s cornea is removed and replaced with donor corneal tissue.
Both DALK and PK are more extensive surgeries than CTAK and generally involve longer recovery periods. They remain valuable treatments for patients whose keratoconus has advanced to a point where less invasive approaches are no longer appropriate. The goal of modern keratoconus care, however, is to identify and treat the disease earlier whenever possible.
So, Where Does CTAK Fit?
CTAK can be thought of as an option between stabilization and transplantation for appropriately selected patients. A patient may have undergone cross-linking and successfully stabilized their keratoconus but still have significant irregularity that affects their vision. Another patient may have stable keratoconus that does not require cross-linking but could benefit from improved corneal shape. In these situations, CTAK may provide another option before considering a DALK or PK.
Importantly, this does not mean every patient follows the same sequence of cross-linking, CTAK, and then transplantation. Some patients may only need cross-linking. Others may benefit from cross-linking followed by CTAK. Some may be candidates for CTAK without first undergoing cross-linking. Patients with advanced disease may already require DALK or PK. The treatment timeline is determined by the individual cornea.
Can CTAK Help Avoid a Corneal Transplant?
For some patients, one of the most important potential advantages of CTAK is the opportunity to improve the cornea without replacing it. By adding donor corneal tissue rather than removing the patient’s cornea, CTAK offers a tissue-preserving approach to reshaping the cornea. For an appropriately selected patient, this may help delay or potentially avoid the need for a more invasive keratoconus surgery such as DALK or PK.
That does not mean CTAK eliminates the need for corneal transplantation in every case. Advanced scarring, severe thinning, or other corneal changes may make transplantation the more appropriate treatment. The key is determining how much healthy corneal tissue remains and what can realistically be achieved with a less invasive approach.
Why Keratoconus Treatment Often Involves More Than One Procedure
It can be tempting to compare keratoconus treatments and ask which one is “best.” But cross-linking, CTAK, and corneal transplantation are not simply competing versions of the same procedure. They address different problems.
- Cross-linking primarily stabilizes a weakening cornea.
- CTAK can improve its shape by adding customized donor tissue.
- DALK or PK replaces corneal tissue when disease has become advanced enough to require transplantation.
That distinction is central to how we approach keratoconus at the Cornea & Laser Eye Institute. Rather than looking at one procedure in isolation, we consider what needs to happen now and what may be possible afterward. Treatment can then become a carefully planned sequence designed around the patient’s disease, corneal anatomy, and visual goals. For some patients, additional vision rehabilitation may also follow stabilization or reshaping of the cornea.
How Do I Know Which Keratoconus Treatment I Need?
The right approach begins with a comprehensive evaluation. Advanced corneal imaging allows us to assess factors including the shape and thickness of the cornea, the location and severity of the cone, and whether the condition appears to be progressing.
At CLEI, your doctor will also consider your current vision, whether you wear glasses or contact lenses, the presence of corneal scarring, previous treatments, and your goals for your vision. Those findings help answer several important questions: Does the cornea need to be stabilized? Could its shape be improved? Is there enough healthy corneal tissue for a procedure such as CTAK? Or has the condition reached a stage where DALK or PK is the better option? Two patients with the same diagnosis of keratoconus may receive very different recommendations because their corneas are different.
The Bottom Line: Keratoconus Treatment Isn’t Either/Or
Cross-linking, CTAK, DALK, and PK each have a place in the treatment of keratoconus. The important question is not which procedure is universally better. It is which treatment, or combination of treatments, is appropriate for your cornea at this point in the disease.
CTAK has expanded the options available to patients by providing a way to add tissue and improve corneal shape without replacing the entire cornea. For some patients, it can serve as an important bridge between stabilization and transplantation. For others, a different approach may make more sense. At CLEI, our goal is to develop a personalized roadmap that addresses the condition you have today while also considering your long-term visual needs.
If you have keratoconus and are unsure which treatment options apply to you, a comprehensive keratoconus evaluation at CLEI is the best place to start. Our team helped develop CTAK and includes three doctors recognized as Top Doctors by the National Keratoconus Foundation. With extensive experience across the full range of keratoconus treatments, we can evaluate your cornea and develop a personalized treatment plan based on your needs, rather than fitting you into a one-size-fits-all approach.
